To see the other types of publications on this topic, follow the link: Drug disease.

Books on the topic 'Drug disease'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 books for your research on the topic 'Drug disease.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

Lippincott Williams & Wilkins., ed. Disease & drug consult. Wolters Kluwer/Lippincott Williams & Wilkins Health, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Lippincott Williams & Wilkins., ed. Disease & drug consult. Wolters Kluwer/Lippincott Williams & Wilkins, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Huml, Raymond A., ed. Rare Disease Drug Development. Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-78605-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

D, Cooper J. Allen, ed. Drug-induced pulmonary disease. W. B. Saunders, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Farrell, Geoffrey C. Drug-induced liver disease. Churchill Livingstone, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Neil, Kaplowitz, and DeLeve Laurie D. 1955-, eds. Drug-induced liver disease. Marcel Dekker, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Neil, Kaplowitz, and DeLeve Laurie D. 1955-, eds. Drug-induced liver disease. Marcel Dekker, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Neil, Kaplowitz, and DeLeve Laurie D. 1955-, eds. Drug-induced liver disease. 2nd ed. Informa Healthcare USA, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Christina, Wolfson, and Canadian Coordinating Office for Health Technology Assessment., eds. Drug treatments for Alzheimer's disease. Canadian Coordinating Office for Health Technology Assessment, 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Droogmans, Steven. Drug-induced valvular heart disease. Nova Science Publishers, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
11

C, Piscitelli Stephen, and Rodvold Keith, eds. Drug interactions in infectious disease. Humana Press, 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
12

J, Sramek John, and Veroff Amy E, eds. Alzheimer's disease: Optimizing drug development strategies. Wiley, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
13

1943-, Howe-Grant Mary, ed. Chemotherapeutics and disease control. Wiley, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
14

Askari, Arman T., and A. Michael Lincoff, eds. Antithrombotic Drug Therapy in Cardiovascular Disease. Humana Press, 2010. http://dx.doi.org/10.1007/978-1-60327-235-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
15

Perneczky, Robert, ed. Biomarkers for Alzheimer’s Disease Drug Development. Springer New York, 2018. http://dx.doi.org/10.1007/978-1-4939-7704-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
16

Zhang, Kang. Ophthalmic disease mechanisms and drug discovery. World Scientific, 2016.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
17

Perneczky, Robert, ed. Biomarkers for Alzheimer’s Disease Drug Development. Springer US, 2024. http://dx.doi.org/10.1007/978-1-0716-3774-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
18

Kumar, Dileep, Vaishali M. Patil, Dee Wu, and Nanasaheb Thorat, eds. Deciphering Drug Targets for Alzheimer’s Disease. Springer Nature Singapore, 2023. http://dx.doi.org/10.1007/978-981-99-2657-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
19

Muñoz-Torrero, Diego, ed. Methods in Neurodegenerative Disease Drug Discovery. Springer US, 2025. https://doi.org/10.1007/978-1-0716-4232-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
20

Zonderman, Jon. Drugs & disease. Chelsea House Publishers, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
21

Peter, Duesberg, ed. AIDS: Virus or drug induced? Kluwer Academic Publishers, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
22

Hamilton, Lucy, and Kearney Brian. The HIV drug book. Edited by Petrow Steven and Project Inform (San Francisco, Calif.). Pocket Books, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
23

1927-, Hamer John, ed. Drugs for heart disease. 2nd ed. Chapman and Hall, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
24

John, Hamer, ed. Drugs for heart disease. 2nd ed. Chapman and Hall, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
25

Wang, Miao, ed. Coronary Artery Disease: Therapeutics and Drug Discovery. Springer Singapore, 2020. http://dx.doi.org/10.1007/978-981-15-2517-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
26

Hardin, Joe G. Handbook of drug therapy in rheumatic disease. Little, Brown, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
27

Keshav, Satish, and Palak Trivedi. Drug-induced liver disease. Edited by Patrick Davey and David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0215.

Full text
Abstract:
Drugs are an important and common cause of hepatic injury. This is unsurprising, as the liver is a major site for drug clearance, biotransformation, and excretion. A careful history of drugs taken (prescribed, over the counter, herbal, or illicit) is vital when assessing anyone with abnormal liver function tests. Although toxic or idiosyncratic adverse reactions may occur with many therapeutic agents, drug-induced jaundice is not so common.
APA, Harvard, Vancouver, ISO, and other styles
28

Ioannides, Costas, and Peter Flatt. Drugs, Diet and Disease Volume 2 (Drug Diet & Disease). Prentice Hall PTR, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
29

Ioannides, Costas, and Peter Flatt. Drugs, Diet and Disease Volume 2 (Drug Diet & Disease). Prentice Hall PTR, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
30

Disease & drug consult. Wolters Kluwer/Lippincott Williams & Wilkins, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
31

Disease & drug consult. Wolters Kluwer Health/Lippincott Williams & Wilkins, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
32

Disease & drug consult. Wolters Kluwer Health/Lippincott Williams & Wilkins, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
33

Loke, Yoon. Drug-induced cardiovascular disease. Edited by Patrick Davey and David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0122.

Full text
Abstract:
Many drugs can cause or exacerbate cardiovascular disease, and clinicians should be vigilant when prescribing potentially cardiotoxic medication to patients at risk, so that preventive measures and close monitoring can be implemented. Conversely, the possibility of drug-related disease should always be considered in patients with cardiovascular symptoms, so that culprit drugs can be identified and alternative therapies considered.
APA, Harvard, Vancouver, ISO, and other styles
34

(Editor), Stephen C. Piscitelli, and Keith A. Rodvold (Editor), eds. Drug Interactions in Infectious Diseases (Infectious Disease). 2nd ed. Humana Press, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
35

(Foreword), Henry Masur, Stephen C. Piscitelli (Editor), and Keith A. Rodvold (Editor), eds. Drug Interactions in Infectious Diseases (Infectious Disease). Humana Press, 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
36

Kaplowitz, Neil, and Laurie D. Deleve. Drug-Induced Liver Disease. Taylor & Francis Group, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
37

Fillit, Howard, Jeffrey Cummings, and Jefferson Kinney. Alzheimer's Disease Drug Development. Cambridge University Press, 2022.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
38

Kaplowitz, Neil, and Laurie D. DeLeve. Drug-Induced Liver Disease. Taylor & Francis Group, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
39

Siddiqui, Salman, and Dhananjay Desai. Drug-induced lung disease. Edited by Patrick Davey and David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0144.

Full text
Abstract:
Pulmonary drug toxicity is being increasingly recognized as a cause of various forms of lung disease. The spectrum of disease can range from transient, minor reactions to rapidly progressive disease with fatal consequences. A large number of drugs are linked to pulmonary disease; however, causality is often difficult to establish, because the length of the latency period between exposure and the onset of disease can vary and because there can be discordance between symptom development and the appearance of radiological changes, which may not be present at all (e.g. angiotensin-converting enzym
APA, Harvard, Vancouver, ISO, and other styles
40

Ferner, Robin, and Anthony Cox. Drug-induced neurological disease. Edited by Patrick Davey and David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0240.

Full text
Abstract:
An adverse drug reaction is defined as ‘an appreciably harmful or unpleasant reaction, resulting from an intervention related to the use of a medicinal product; adverse effects usually predict hazard from future administration and warrant prevention, or specific treatment, or alteration of the dosage regimen, or withdrawal of the product’ (p. 1255, Edwards IR and Aronson JK. Adverse drug reactions: Definitions, diagnosis, and management. Lancet 2000; 356: 1255–9). Adverse drug reactions can cause or contribute to central and peripheral nervous system disorders, including traumatic, infective,
APA, Harvard, Vancouver, ISO, and other styles
41

Sivaramakrishnan, Muthu. Drug-induced skin disease. Edited by Patrick Davey and David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0261.

Full text
Abstract:
Drug-induced skin disease is one of the commonest dermatological presentations in both hospitalized and ambulatory patients. It affects 2%–3% of hospitalized patients, and it is estimated that 1 in 1000 hospitalized patients has a serious cutaneous drug reaction. The clinical presentation can mimic any skin disease and should be considered in the differential diagnosis of any acute-onset symmetrical skin eruption. It is important to make a correct diagnosis, as removal of the offending drug results in clinical resolution in most instances.
APA, Harvard, Vancouver, ISO, and other styles
42

Kaplowitz, Neil. Drug-Induced Liver Disease. CRC Press, 2002. http://dx.doi.org/10.1201/b15279.

Full text
APA, Harvard, Vancouver, ISO, and other styles
43

Cummings, Jeffrey, Jefferson Kinney, and Howard Fillit, eds. Alzheimer's Disease Drug Development. Cambridge University Press, 2022. http://dx.doi.org/10.1017/9781108975759.

Full text
Abstract:
Alzheimer's Disease (AD) is a growing global public health challenge. The development of new therapies is urgently needed, and a complex ecosystem of organizations has grown to facilitate AD drug discovery and development. Masterfully collating information on the drug development ecosystem, this book emphasizes the contributions of each aspect in the pipeline with a uniform approach to chapters, enabling readers to access relevant information quickly. Topics covered include the use of non-clinical laboratory studies, biomarker development, artificial intelligence, design and management of clin
APA, Harvard, Vancouver, ISO, and other styles
44

Drug-Induced Liver Disease. Elsevier, 2013. http://dx.doi.org/10.1016/c2010-0-68917-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
45

Huang, Xudong, ed. Alzheimer’s Disease: Drug Discovery. Exon Publications, 2020. http://dx.doi.org/10.36255/exonpublications.alzheimersdisease.2020.

Full text
APA, Harvard, Vancouver, ISO, and other styles
46

Kaplowitz, Neil. Drug-Induced Liver Disease. Edited by Neil Kaplowitz and Laurie D. DeLeve. CRC Press, 2007. http://dx.doi.org/10.3109/9781420021141.

Full text
APA, Harvard, Vancouver, ISO, and other styles
47

Kaplowitz, Neil, and Laurie D. DeLeve. Drug-Induced Liver Disease. Taylor & Francis Group, 2020.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
48

Drug-Induced Liver Disease. Elsevier Science & Technology Books, 2013.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
49

(Editor), Neil Kaplowitz, and Laurie D. DeLeve (Editor), eds. Drug-Induced Liver Disease. Informa Healthcare, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
50

Kaplowitz, Neil, and Laurie D. DeLeve. Drug-Induced Liver Disease. Taylor & Francis Group, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!